Positive Clinical Breast Cancer Data Presented for NuView’s Molecular…

Next generation PET imaging agent identifies 100% of malignant breast cancer tumors in clinical trial and displays potential to replace many invasive biopsy procedures.

(PRWeb March 13, 2013)

Read the full story at http://www.prweb.com/releases/2013/3/prweb10520654.htm

Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.